Consainsights logo
Reports / Duchenne Muscular Dystrophy Therapeutics Market

Duchenne Muscular Dystrophy Therapeutics Market

Duchenne Muscular Dystrophy Therapeutics Market Research Report – Segmented By Treatment Type (CORTECOSTEROIDS, PAIN MANAGEMENT DRUDS), End User (CLINICS, HOME CARE SETTINGS, HOSPITALS), Region (ASIA-PACIFIC, EUROPE, LAMEA) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Duchenne Muscular Dystrophy Therapeutics Market from Consainsights analyses the Duchenne Muscular Dystrophy Therapeutics Market in the Life Sciences industry over the forecast period to 2026.

Duchenne Muscular Dystrophy Therapeutics research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Duchenne Muscular Dystrophy Therapeutics segmentation includes Treatment Type, End User, Region and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Treatment Type, the Duchenne Muscular Dystrophy Therapeutics Market analysis covers CORTECOSTEROIDS, PAIN MANAGEMENT DRUDS.

Based on the End User, the Duchenne Muscular Dystrophy Therapeutics Market analysis covers CLINICS, HOME CARE SETTINGS, HOSPITALS.

Based on the Region, the Duchenne Muscular Dystrophy Therapeutics Market analysis covers ASIA-PACIFIC, EUROPE, LAMEA.

Key companies operating in the market include BRISTOL-MYERS SQUIBB COMPANY, FIBROGEN, INC., ITALFARMACO S.P.A., MARATHON PHARMACEUTICALS, LLC, NS PHARMA, INC, PTC THERAPEUTICS, INC., PFIZER INC., REVERAGEN BIOPHARMA, INC., SANTHERA PHARMACEUTICALS, SAREPTA THERAPEUTICS, INC and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

  • Revenue Share (%), By Treatment Type (2019)
    Revenue Share (%), By Treatment Type (2019)
  • Revenue Share (%), By End User (2019)
    Revenue Share (%), By End User (2019)
  • Revenue Share (%), By Region (2019)
    Revenue Share (%), By Region (2019)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Treatment Type

By Treatment Type, The Global Duchenne Muscular Dystrophy Therapeutics Market analysis covers CORTECOSTEROIDS, PAIN MANAGEMENT DRUDS.

Global Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (Us$ Mn), By Treatment Type, 2019-2027
Global Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (Us$ Mn), By Treatment Type, 2019-2027

The CORTECOSTEROIDS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

CORTECOSTEROIDS: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)
CORTECOSTEROIDS: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)

The PAIN MANAGEMENT DRUDS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

PAIN MANAGEMENT DRUDS: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)
PAIN MANAGEMENT DRUDS: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)
04

By End User

By End User, The Global Duchenne Muscular Dystrophy Therapeutics Market analysis covers CLINICS, HOME CARE SETTINGS, HOSPITALS.

Global Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (Us$ Mn), By End User, 2019-2027
Global Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (Us$ Mn), By End User, 2019-2027

The CLINICS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

CLINICS: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)
CLINICS: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)

The HOME CARE SETTINGS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

HOME CARE SETTINGS: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)
HOME CARE SETTINGS: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)

The HOSPITALS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

HOSPITALS: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)
HOSPITALS: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)
05

By Region

By Region, The Global Duchenne Muscular Dystrophy Therapeutics Market analysis covers ASIA-PACIFIC, EUROPE, LAMEA.

Global Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (Us$ Mn), By Region, 2019-2027
Global Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (Us$ Mn), By Region, 2019-2027

The ASIA-PACIFIC segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

ASIA-PACIFIC: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)
ASIA-PACIFIC: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)

The EUROPE segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

EUROPE: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)
EUROPE: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)

The LAMEA segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

LAMEA: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)
LAMEA: Global Duchenne Muscular Dystrophy Therapeutics Market Revenue Opportunity (Us$ Mn)
06

North America

Based on the North America, the Duchenne Muscular Dystrophy Therapeutics Market analysis covers United States, Canada.

North America Map
North America Duchenne Muscular Dystrophy Therapeutics Market Size, 2019-2027 (Us$ Mn)
North America Duchenne Muscular Dystrophy Therapeutics Size, 2019-2027 (Us$ Mn)
North America Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
North America Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
North America Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
North America Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
United States Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
United States Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
United States Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
United States Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Canada Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Canada Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Canada Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Canada Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
07

Europe

Based on the Europe, the Duchenne Muscular Dystrophy Therapeutics Market analysis covers Germany, United Kingdom, France, Spain, Russia, Italy, Rest of Europe.

Europe Map
Europe Duchenne Muscular Dystrophy Therapeutics Market Size, 2019-2027 (Us$ Mn)
Europe Duchenne Muscular Dystrophy Therapeutics Size, 2019-2027 (Us$ Mn)
Europe Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Europe Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Europe Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Europe Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Germany Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Germany Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Germany Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Germany Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
United Kingdom Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
United Kingdom Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
United Kingdom Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
United Kingdom Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
France Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
France Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
France Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
France Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Spain Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Spain Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Spain Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Spain Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Russia Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Russia Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Russia Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Russia Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Italy Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Italy Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Italy Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Italy Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Europe Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Rest of Europe Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Rest of Europe Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Europe Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
08

Asia-Pacific

Based on the Asia-Pacific, the Duchenne Muscular Dystrophy Therapeutics Market analysis covers China, Japan, India, Southeast Asia, Australia & New Zealand, Rest of Asia-Pacific.

Asia-Pacific Map
Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Market Size, 2019-2027 (Us$ Mn)
Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Size, 2019-2027 (Us$ Mn)
Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
China Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
China Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
China Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
China Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Japan Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Japan Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Japan Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Japan Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
India Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
India Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
India Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
India Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Australia & New Zealand Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Australia & New Zealand Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Australia & New Zealand Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Australia & New Zealand Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Rest of Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Rest of Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Asia-Pacific Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
09

Middle East & Africa

Based on the Middle East & Africa, the Duchenne Muscular Dystrophy Therapeutics Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Size, 2019-2027 (Us$ Mn)
Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Middle East Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Middle East Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Middle East Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Middle East Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Africa Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Africa Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Africa Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Africa Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Rest of Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Rest of Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
10

Latin America

Based on the Latin America, the Duchenne Muscular Dystrophy Therapeutics Market analysis covers Brazil, Argentina, Mexico, Colombia, Rest of Latin America.

Latin America Map
Latin America Duchenne Muscular Dystrophy Therapeutics Market Size, 2019-2027 (Us$ Mn)
Latin America Duchenne Muscular Dystrophy Therapeutics Size, 2019-2027 (Us$ Mn)
Latin America Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Latin America Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Latin America Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Latin America Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Brazil Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Brazil Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Brazil Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Brazil Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Argentina Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Argentina Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Argentina Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Argentina Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Mexico Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Mexico Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Mexico Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Mexico Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Colombia Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Colombia Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Colombia Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Colombia Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Latin America Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Rest of Latin America Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Treatment Type, 2019-2027
Rest of Latin America Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
Rest of Latin America Duchenne Muscular Dystrophy Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027
11

Company Analysis

  • BRISTOL-MYERS SQUIBB COMPANY
  • FIBROGEN, INC.
  • ITALFARMACO S.P.A.
  • MARATHON PHARMACEUTICALS, LLC
  • NS PHARMA, INC
  • PTC THERAPEUTICS, INC.
  • PFIZER INC.
  • REVERAGEN BIOPHARMA, INC.
  • SANTHERA PHARMACEUTICALS
  • SAREPTA THERAPEUTICS, INC